Vericel on Track for Over 30% MACI Growth in 2021

By Mike Evers

Vericel on Track for Over 30% MACI Growth in 2021
Armed with expanded coverage from UnitedHealthcare, Vericel expects to growth MACI in the low- to mid- +30% range in 2021.

Member-Only Content

SUBSCRIBE Login

Product Labels: Orthobiologic Soft Tissue Repair

Tags: Revenue Report